ISR Immune System Regulation Holding AB (publ) (ISR.ST) Research

ISR Immune System Regulation Holding AB (publ), headquartered in Stockholm, Sweden, is dedicated to the discovery and development of pharmaceutical solutions for viral infections. Its current therapeutic pipeline features a Covid-19 vaccine candidate, treatments for Hepatitis B (HBV) and HIV, and an oncology program.

Market snapshot

Symbol
ISR.ST
Price
$1.40
Day change
0.00%
Market cap
$96.6M
P/E ratio
-1.23x
52-week range
1.191-9.25
Sector
Healthcare
Industry
Biotechnology

Peer companies

  • Amniotics AB (publ) (AMNI.ST)
  • Asarina Pharma AB (publ) (ASAP.ST)
  • CombiGene AB (publ) (COMBI.ST)
  • Cyxone AB (publ) (CYXO.ST)
  • Idogen AB (publ) (IDOGEN.ST)
  • Kancera AB (publ) (KAN.ST)
  • Pharmiva AB (publ) (PHARM.ST)
  • Scandion Oncology A/S (SCOL.ST)

Open ISR Immune System Regulation Holding AB (publ) (ISR.ST) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.